CYNAPSUS THERAPEUTICS INC's ticker is and the CUSIP is 23257Y156. A total of 1 filers reported holding CYNAPSUS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $564,000 | +35.6% | 33,995 | 0.0% | 0.45% | +24.5% |
| Q1 2016 | $416,000 | -20.9% | 33,995 | 0.0% | 0.36% | -23.5% |
| Q4 2015 | $526,000 | -1.9% | 33,995 | 0.0% | 0.47% | -11.8% |
| Q3 2015 | $536,000 | -4.1% | 33,995 | 0.0% | 0.53% | +12.5% |
| Q2 2015 | $559,000 | +7.3% | 33,995 | -93.8% | 0.47% | +18.2% |
| Q1 2015 | $521,000 | +117.1% | 543,927 | +93.7% | 0.40% | +110.5% |
| Q4 2014 | $240,000 | +61.1% | 280,769 | 0.0% | 0.19% | +26.7% |
| Q3 2014 | $149,000 | – | 280,769 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 33,995 | $564,000 | 0.45% |